Blood Research

Download original image

Prophylactic management of venous thromboembolism (VTE).

a)Dexamethasone 480 mg/month. b)Elderly patients aged ≥75 years, history of VTE, ECOG PS 2 or more, medical comorbidity such as infection, renal disease, pulmonary disease, congestive heart failure, arterial thromboembolism, hereditary or acquired thrombophilia, concomitant erythropoietin therapy, body mass index ≥30 kg/m2 [56, 64].

Abbreviations: ClCr, creatinine clearance; ECOG PS, Eastern Cooperative Oncology Group performance status; INR, International Normalized Ratio; LMWH, low molecular-weight heparin.

© Blood Research
© 2024. BLOOD RESEARCH All rights reserved. Powered by INFOrang Co., Ltd